台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.25
  • 漲跌
    ▼0.05
  • 漲幅
    -0.11%
  • 成交量
    59
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-元大-莒光 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1805/3006/0806/2212/2002/2403/0607/0607/2208/0208/1608/3009/1409/3010/1210/2611/0811/2212/0601/0401/1402/0202/1203/08404244464850May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-莒光 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/0300.00144.9044.60-1153-0.65%
2025/02/2600.00145.5045.80-1150-0.66%
2025/02/17045.3500.0044.7501620.00%
2025/02/1100.00243.4543.75-2176-1.14%
2025/01/2200.00442.2542.30-4228-1.75%
2025/01/21142.1000.0042.7013440.29%
2025/01/1000.00143.6043.35-1387-0.26%
2025/01/07343.1500.0042.8033890.77%
2025/01/0600.00343.4043.40-3395-0.76%
2024/12/2700.00144.7044.25-1421-0.24%
2024/12/26144.5000.0044.0514290.23%
2024/11/19644.90645.3245.4506880.00%
2024/11/1800.001245.1244.10-12699-1.72%
2024/11/1500.00346.4046.25-3696-0.43%
2024/11/061050.2500.0049.35107461.34%
2024/10/29252.5000.0052.1027720.26%
2024/10/28655.45755.9352.60-1756-0.13%
2024/10/2500.000.254.4054.40-0.2645-0.03%
2024/10/1100.00149.0048.95-11,063-0.09%
2024/09/2000.00153.9055.00-11,023-0.10%
2024/09/19655.7500.0053.2069950.60%
2024/09/1800.000.152.3052.30-0.1943-0.01%
2024/09/13548.3100.0047.8059670.52%
2024/09/09749.24648.2048.2011,0340.10%
2024/09/0500.00247.2547.40-21,018-0.20%
2024/09/0400.000.148.0347.85-0.11,017-0.01%
2024/08/22449.78151.4049.8039620.31%
2024/08/2100.00951.1950.60-9948-0.95%
2024/08/200.151.50251.8050.90-1.9943-0.21%
2024/08/19149.8500.0049.8019300.11%
2024/08/151049.9800.0049.60109171.09%
2024/08/1400.00147.9547.05-1901-0.11%
2024/08/13147.1500.0047.1018940.11%
2024/08/07151.5000.0050.7018560.12%
2024/07/2300.00153.4054.10-1770-0.13%
2024/07/19361.20460.7558.10-1735-0.14%
2024/07/18961.23262.2062.2076581.06%
2024/07/17358.90558.3458.90-2543-0.37%
2024/07/16256.00956.4757.20-7427-1.64%
2024/07/1500.00252.0052.00-2337-0.59%
2024/07/12547.0000.0047.3053281.52%
2024/07/0900.001043.3043.40-10319-3.13%
2024/07/0500.00145.2045.65-1312-0.32%
2024/07/0200.001.346.3745.50-1.3307-0.42%
2024/06/261.348.5500.0048.751.32880.45%
2024/06/191047.9500.0047.95102244.45%
2024/06/18345.92544.7444.00-2213-0.94%
2024/06/17345.3300.0045.3531871.60%
2024/05/2400.00241.3041.45-2170-1.17%
2024/05/17042.0000.0042.4501770.00%
2024/04/29041.5000.0041.3001830.00%
2024/04/1900.00241.0540.70-2186-1.07%
2024/04/1800.00242.0041.90-2182-1.10%
2024/04/1500.00242.3542.30-2187-1.06%
2024/04/02243.6000.0043.9521921.04%
2024/04/01245.1500.0044.4021931.03%
2024/03/29043.9500.0044.1001980.00%
2024/03/28043.4500.0043.4001990.00%
2024/03/21243.25142.8042.7012000.50%
2024/03/1900.00441.9641.65-4199-2.01%
2024/03/18242.5000.0042.2521991.00%
2024/03/1500.00542.9042.90-5200-2.49%
2024/03/13043.9500.0042.6002090.00%
2024/03/11042.9000.0042.6502230.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音